AbCellera to Present at Upcoming Investor Conferences in March and April 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:
- TD Cowen 46th Annual Health Care Conference, March 4, 2026
- KeyBanc Capital Markets Healthcare Forum, March 17, 2026
- Bloom Burton & Co. Healthcare Investor Conference, April 21-22, 2026
A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.
Contacts
Inquiries
Media: Tiffany Chiu; media@abcellera.com, +1(236)521-6774
Partnering: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005
Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116
Editor Details
-
Company:
- Businesswire
